Position
Squarepoint Ops LLC in Tarsus Pharmaceuticals, Inc.
Back to the book · All holders of TARS
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$256.1K$81.88 → $70.15
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 21.8K | $1.79M | — | — | — | 0.0% |
| Q1 2026 | 241K | $16.9M | $70.15 | −$256.1K | $15.4M | 0.0% |